{
    "medicine_id": "0d30ee4bda5777908c164e7493156922806a3b1b",
    "platform_id": "DB06245",
    "metadata": {
        "name": "Vaniqa 139 mg 1g Cream",
        "composition": "139 mg 1g Lanoteplase",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in myocardial infarction",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of angioedema can be increased when Alteplase is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "The risk or severity of angioedema can be increased when Urokinase is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of angioedema can be increased when Reteplase is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of angioedema can be increased when Anistreplase is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of angioedema can be increased when Tenecteplase is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of angioedema can be increased when Streptokinase is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "The risk or severity of angioedema can be increased when Valsartan is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "The risk or severity of angioedema can be increased when Ramipril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of angioedema can be increased when Pregabalin is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "The risk or severity of angioedema can be increased when Fosinopril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "The risk or severity of angioedema can be increased when Trandolapril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "The risk or severity of angioedema can be increased when Benazepril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of angioedema can be increased when Enalapril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of angioedema can be increased when Diclofenac is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of angioedema can be increased when Losartan is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of angioedema can be increased when Moexipril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "The risk or severity of angioedema can be increased when Lisinopril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "The risk or severity of angioedema can be increased when Perindopril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "The risk or severity of angioedema can be increased when Eprosartan is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The risk or severity of angioedema can be increased when Sirolimus is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "The risk or severity of angioedema can be increased when Quinapril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of angioedema can be increased when Omapatrilat is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of angioedema can be increased when Acetylsalicylic acid is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "The risk or severity of angioedema can be increased when Telmisartan is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of angioedema can be increased when Ibuprofen is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of angioedema can be increased when Rescinnamine is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of angioedema can be increased when Captopril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The risk or severity of angioedema can be increased when Sitagliptin is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "The risk or severity of angioedema can be increased when Cilazapril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB01342",
                        "description": "The risk or severity of angioedema can be increased when Forasartan is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "The risk or severity of angioedema can be increased when Saprisartan is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "The risk or severity of angioedema can be increased when Spirapril is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB04876",
                        "description": "The risk or severity of angioedema can be increased when Vildagliptin is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB06011",
                        "description": "The risk or severity of angioedema can be increased when AMG 222 is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB06127",
                        "description": "The risk or severity of angioedema can be increased when Bisegliptin is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "The risk or severity of angioedema can be increased when Icatibant is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The risk or severity of angioedema can be increased when Alogliptin is combined with Lanoteplase"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Saxagliptin"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Amediplase"
                    },
                    {
                        "drugbank-id": "DB08382",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Gosogliptin"
                    },
                    {
                        "drugbank-id": "DB08822",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Azilsartan medoxomil"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Temocapril"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Sacubitril"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11723",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Dutogliptin"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Imidapril"
                    },
                    {
                        "drugbank-id": "DB11950",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Teneligliptin"
                    },
                    {
                        "drugbank-id": "DB11992",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Omarigliptin"
                    },
                    {
                        "drugbank-id": "DB12268",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Carmegliptin"
                    },
                    {
                        "drugbank-id": "DB12412",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Gemigliptin"
                    },
                    {
                        "drugbank-id": "DB12417",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Anagliptin"
                    },
                    {
                        "drugbank-id": "DB12625",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Evogliptin"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Delapril"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Saruplase"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14209",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Trandolaprilat"
                    },
                    {
                        "drugbank-id": "DB14210",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Moexiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of angioedema can be increased when Lanoteplase is combined with Quinoline Yellow WS"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}